Active Switch From a Single Dose of Bimekizumab to Risankizumab in Psoriasis: A Pilot Study. Nakajima K, Miyagaki T, Okano T, Kadono T, et al. J Dermatol 2025 Apr 22. doi: 10.1111/1346-8138.17760.

Read + Share

Amedeo Smart

Independent Medical Education

Nakajima K, Miyagaki T, Okano T, Kadono T, et al. Active Switch From a Single Dose of Bimekizumab to Risankizumab in Psoriasis: A Pilot Study. J Dermatol 2025 Apr 22. doi: 10.1111/1346-8138.17760.
PMID: 40260930